Related Experiment Video
Updated: Jun 24, 2026

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
Published on: October 6, 2023
Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation
1Division of Pediatric Emergency Medicine, Children's Medical Center of Dallas, Medical Toxicology, North Texas Poison Center, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75235, USA. collin.goto@childrens.com
Insights
Crotaline snakebites in children cause significant illness. Crotalidae Polyvalent Immune Fab antivenom (FabAV) effectively reduces morbidity from these venomous snakebites in pediatric patients.
Area of Science:
- Pediatric Emergency Medicine
- Toxicology
- Pharmacology
Background:
- Crotaline snakebites are a common pediatric emergency.
- These envenomations frequently lead to substantial morbidity in children.
- Crotalidae Polyvalent Immune Fab antivenom (FabAV) is the current standard of care in the US.
Purpose of the Study:
- To review the clinical use of FabAV in treating pediatric crotaline envenomation.
- To emphasize the importance of FabAV for emergency care providers treating children.
- To highlight FabAV's role in mitigating snakebite morbidity.
Main Methods:
- Literature review on FabAV efficacy in pediatric patients.
- Analysis of clinical guidelines for antivenom use.
- Synthesis of data on morbidity reduction post-FabAV administration.
Main Results:
- FabAV became available in the US in 2000.
- Judicious use of FabAV is associated with decreased morbidity.
- Familiarity with FabAV is crucial for pediatric emergency care providers.
Conclusions:
- FabAV is a critical therapeutic agent for pediatric crotaline envenomation.
- Effective management of pediatric snakebites relies on appropriate FabAV administration.
- Early and judicious FabAV use can significantly improve outcomes for children with crotaline snakebites.
Abstract:
Crotaline snakebites occur frequently in children, often resulting in significant morbidity. Crotalidae Polyvalent Immune Fab antivenom (FabAV) became available for clinical use in the US in 2000 and is currently the standard of care for the treatment of crotaline envenomation. The pediatric emergency care provider should be familiar with FabAV because its judicious use in affected children can greatly decrease morbidity caused by crotaline snakebites. This article will review the use of FabAV for the treatment of pediatric crotaline envenomation.
More Related Videos
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
10:25Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
Published on: November 3, 2014
Related Concept Videos
Anthelminthic Agents
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies
Prevention of Further Absorption of Poison